Instil Bio Inc logo

TIL - Instil Bio Inc Share Price

$21.03 -1.0  -4.5%

Last Trade - 2:46pm

Small Cap
Market Cap £275.8m
Enterprise Value £275.8m
Revenue £101k
Position in Universe 3860th / 6827
Unlock TIL Revenue
Relative Strength (%)
1m +429.5%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -25.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.14
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, InstilBio Inc revenues increased from $0K to $138K. Net lossincreased from $6.5M to $37.7M. Revenues reflect anincrease in demand for the Company's products and servicesdue to favorable market conditions. Higher net lossreflects Research and development - Balancing increase from$4M to $19M (expense), General and administrative -Balancing increase from $2.3M to $13.1M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


TIL Revenue Unlock TIL Revenue

Net Income

TIL Net Income Unlock TIL Revenue

Normalised EPS

TIL Normalised EPS Unlock TIL Revenue

PE Ratio Range

TIL PE Ratio Range Unlock TIL Revenue

Dividend Yield Range

TIL Dividend Yield Range Unlock TIL Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
TIL EPS Forecasts Unlock TIL Revenue
Profile Summary

Instil Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing cell therapy pipeline of autologous tumor infiltrating lymphocyte (TIL) therapies for the treatment of patients with cancer. It is advancing its lead TIL product candidate, ITIL-168, for the treatment of advanced melanoma. It is also developing a class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR) platform. ITIL-168 is an autologous TIL therapy that it is initially developing for the treatment of PD-1-inhibitor relapsed or refractory advanced melanoma. Its pipeline also includes ITIL-306, its lead CoStAR-TIL product candidate. ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (FOLR1), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer.

Last Annual December 31st, 2020
Last Interim January 1st, 1970
Incorporated August 31, 2018
Public Since March 19, 2021
No. of Shareholders: n/a
No. of Employees: 150
Sector Healthcare
Industry Biotechnology & Medical Research
Index Nasdaq Composite ,
Exchange NASDAQ Global Select Market
Shares in Issue 17,159,642
Free Float (0.0%)
Eligible for
TIL Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for TIL
Upcoming Events for TIL
Frequently Asked Questions for Instil Bio Inc
What is the Instil Bio Inc share price?

As of 2:46pm, shares in Instil Bio Inc are trading at $21.03, giving the company a market capitalisation of £275.8m. This share price information is delayed by 15 minutes.

How has the Instil Bio Inc share price performed this year?

Shares in Instil Bio Inc are currently trading at $21.03 and the price has moved by 0.451k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Instil Bio Inc price has moved by 0.271k% over the past year.

What are the analyst and broker recommendations for Instil Bio Inc?

There are no analysts currently covering Instil Bio Inc.

When will Instil Bio Inc next release its financial results?

It is not known when Instil Bio Inc will next release financial results.

What is the Instil Bio Inc dividend yield?

Instil Bio Inc does not currently pay a dividend.

Does Instil Bio Inc pay a dividend?

Instil Bio Inc does not currently pay a dividend.

When does Instil Bio Inc next pay dividends?

Instil Bio Inc does not currently pay a dividend.

How do I buy Instil Bio Inc shares?

To buy shares in Instil Bio Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Instil Bio Inc?

Shares in Instil Bio Inc are currently trading at $21.03, giving the company a market capitalisation of £275.8m.

Where are Instil Bio Inc shares listed? Where are Instil Bio Inc shares listed?

Here are the trading details for Instil Bio Inc:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: TIL
What kind of share is Instil Bio Inc?

Based on an overall assessment of its quality, value and momentum, Instil Bio Inc is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Instil Bio Inc share price forecast 2021?

We were not able to load any forecast data for Instil Bio Inc.

How can I tell whether the Instil Bio Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Instil Bio Inc. Over the past six months, the relative strength of its shares against the market has been 0.375k%. At the current price of $21.03, shares in Instil Bio Inc are trading at 0.293k% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Instil Bio Inc PE Ratio?

We were not able to find PE ratio data for Instil Bio Inc.

Who are the key directors of Instil Bio Inc?

We were unable to find the directors for Instil Bio Inc.

Who are the major shareholders of Instil Bio Inc?

Here are the top five shareholders of Instil Bio Inc based on the size of their shareholding:

Vivo Capital, LLC Venture Capital
Percentage owned: 9.92% (12.5m shares)
Mcgaughy R Kent Jr Individual Investor
Percentage owned: 6.74% (8.48m shares)
Laumas (Sandeep) Individual Investor
Percentage owned: 2.54% (3.20m shares)
Crouch (Bronson) Individual Investor
Percentage owned: 2.02% (2.54m shares)
SB2A Management LLC Corporation
Percentage owned: 1.91% (2.40m shares)
Similar to TIL
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.